Generic Product News (July 2016)

Pharmacy Times, July 2016 Digestive Health, Volume 82, Issue 7

Read about the new generic products featured in July.

Teva Pharmaceuticals

COMPARE TO: Lescol (Novartis)

INDICATION: Teva Pharmaceuticals recently announced the availability of Fluvastatin Sodium Extended-Release Tablets, the therapeutic equivalent to Novartis’ Lescol XL. The product is a lipid-lowering agent indicated as an adjunct to diet to treat primary hypercholesterolemia and mixed dyslipidemia.

DOSAGE FORMS: 80 mg

FOR MORE INFORMATION: tevapharm.com

METHYLPHENIDATE, USPMARKETED BY: Camber Pharmaceuticals, Inc

COMPARE TO: Ritalin (Novartis)

INDICATION: Camber Pharmaceuticals recently launched Methylphenidate, USP, the generic equivalent of Novartis’ Ritalin, in 5-, 10-, and 20-mg dosage strengths. The product is indicated to treat attention-deficit/hyperactivity disorder and narcolepsy.

DOSAGE FORM: Tablets: 5, 10, and 20 mg

FOR MORE INFORMATION: camberpharma.com

DOFETILIDE CAPSULESMARKETED BY: Mayne Pharma

COMPARE TO: Tikosyn (Pfizer)

INDICATION: Mayne Pharma recently announced the launch of its Dofetilide Capsules, the therapeutic equivalent to Pfizer’s Tikosyn. The product is an antiarrhythmic agent indicated to treat irregular heartbeats, such as in atrial fibrillation and atrial flutter.

DOSAGE FORM: Capsules: 125, 250, and 500 mcg

FOR MORE INFORMATION: maynepharma.com

DICLOFENAC SODIUM GEL 3%MARKETED BY: Taro Pharmaceuticals

COMPARE TO: Solaraze Gel (PharmaDerm)

INDICATION: Taro Pharmaceuticals recently announced the launch of its Diclofenac Sodium Gel 3%, the generic equivalent to PharmaDerm’s Solaraze. The topical gel is indicated to treat actinic keratosis. It should be applied twice daily to the lesion areas. Sun avoidance is indicated during therapy.

DOSAGE FORM: Gel: 3%

FOR MORE INFORMATION: taro.com